Long-Term Stimulant Treatment Affects Brain Dopamine Transporter Level in Patients with Attention Deficit Hyperactive Disorder

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Wang, Gene Jack ^a,b,c   Volkow, Nora D ^d,e   Wigal, Timothy ^f   Kollins, Scott H ^g   Newcorn, Jeffrey H ^c   Telang, Frank ^e   Logan, Jean ^b   Jayne, Millard ^e   Wong, Christopher T ^e   Han, Hao ^a   Fowler, Joanna S ^b,c   Zhu, Wei ^a   Swanson, James M ^f  

^a STONY BROOK UNIVERSITY   (United States)

^b BROOKHAVEN NATIONAL LABORATORY   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^e Intramural Program   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE C 11; DOPAMINE TRANSPORTER; METHYLPHENIDATE; TRACER; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; MALE; NERVE CELL PLASTICITY; NEUROIMAGING; PET SCANNER; POSITRON EMISSION TOMOGRAPHY; PUTAMEN; UPREGULATION;

ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CASE-CONTROL STUDIES; CAUDATE NUCLEUS; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HUMANS; MALE; METHYLPHENIDATE; NEUROIMAGING; POSITRON-EMISSION TOMOGRAPHY; PUTAMEN; RADIOPHARMACEUTICALS; YOUNG ADULT;

EID: 84877766209     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063023     Document Type: Article

References (29)

1. Del Campo N, Chamberlain SR, Sahakian BJ, Robbins TW, (2011) The roles of dopamine and noradrenaline in the pathophysiology and treatment of attention-deficit/hyperactivity disorder. Biological psychiatry 69: e145-157.
2. Swanson JM, Volkow ND, (2009) Psychopharmacology: concepts and opinions about the use of stimulant medications. J Child Psychol Psychiatry 50: 180-193.
3. Rosa-Neto P, Lou HC, Cumming P, Pryds O, Karrebaek H, et al. (2005) Methylphenidate-evoked changes in striatal dopamine correlate with inattention and impulsivity in adolescents with attention deficit hyperactivity disorder. Neuroimage 25: 868-876.
4. Volkow ND, Wang GJ, Tomasi D, Kollins SH, Wigal TL, et al. (2012) Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder. Journal of neuroscience 32: 841-849.
5. Volkow ND, Wang GJ, Kollins SH, Wigal TL, Newcorn JH, et al. (2009) Evaluating dopamine reward pathway in ADHD: clinical implications. JAMA 302: 1084-1091.
6. Hamilton M, (1959) The assessment of anxiety states by rating. Br J Med Psychol 32: 50-55.
7. Hamilton M, (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56-62.
8. Conners CK, (1998) Rating scales in attention-deficit/hyperactivity disorder: use in assessment and treatment monitoring. J Clin Psychiatry 59 Suppl 7: 24-30.
9. Swanson J, Lerner M, March J, Gresham FM, (1999) Assessment and intervention for attention-deficit/hyperactivity disorder in the schools. Lessons from the MTA study. Pediatr Clin North Am 46: 993-1009.
10. Pliszka SR, Carlson CL, Swanson JM (1999) Behavioral assessment. New York: Guilford Press.
11. Volkow ND, Wang GJ, Newcorn J, Fowler JS, Telang F, et al. (2007) Brain dopamine transporter levels in treatment and drug naive adults with ADHD. Neuroimage 34: 1182-1190.
12. Alexoff DL, Shea C, Fowler JS, King P, Gatley SJ, et al. (1995) Plasma input function determination for PET using a commercial laboratory robot. Nucl Med Biol 22: 893-904.
13. Logan J, Fowler JS, Volkow ND, Wolf AP, Dewey SL, et al. (1990) Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab 10: 740-747.
14. Gulley JM, Zahniser NR, (2003) Rapid regulation of dopamine transporter function by substrates, blockers and presynaptic receptor ligands. Eur J Pharmacol 479: 139-152.
15. Zahniser NR, Doolen S, (2001) Chronic and acute regulation of Na+/Cl- dependent neurotransmitter transporters: drugs, substrates, presynaptic receptors, and signaling systems. Pharmacol Ther 92: 21-55.
16. Koff JM, Shuster L, Miller LG, (1994) Chronic cocaine administration is associated with behavioral sensitization and time-dependent changes in striatal dopamine transporter binding. J Pharmacol Exp Ther 268: 277-282.
17. Little KY, Zhang L, Desmond T, Frey KA, Dalack GW, et al. (1999) Striatal dopaminergic abnormalities in human cocaine users. Am J Psychiatry 156: 238-245.
18. Malison RT, Best SE, van Dyck CH, McCance EF, Wallace EA, et al. (1998) Elevated striatal dopamine transporters during acute cocaine abstinence as measured by [123I] beta-CIT SPECT. Am J Psychiatry 155: 832-834.
19. Sproson EJ, Chantrey J, Hollis C, Marsden CA, Fonel KC, (2001) Effect of repeated methylphenidate administration on presynaptic dopamine and behaviour in young adult rats. J Psychopharmacol 15: 67-75.
20. Volkow ND, Wang GJ, Tomasi D, Kollins S, Wigal T, et al. (2013) Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with ADHD. Journal of neuroscience In press.
21. Crawford CA, McDougall SA, Meier TL, Collins RL, Watson JB, (1998) Repeated methylphenidate treatment induces behavioral sensitization and decreases protein kinase A and dopamine-stimulated adenylyl cyclase activity in the dorsal striatum. Psychopharmacology (Berl) 136: 34-43.
22. McNamara CG, Davidson ES, Schenk S, (1993) A comparison of the motor-activating effects of acute and chronic exposure to amphetamine and methylphenidate. Pharmacol Biochem Behav 45: 729-732.
23. Kuczenski R, Segal DS, (2002) Exposure of adolescent rats to oral methylphenidate: preferential effects on extracellular norepinephrine and absence of sensitization and cross-sensitization to methamphetamine. J Neurosci 22: 7264-7271.
24. Andersen SL, Arvanitogiannis A, Pliakas AM, LeBlanc C, Carlezon WA Jr, (2002) Altered responsiveness to cocaine in rats exposed to methylphenidate during development. Nat Neurosci 5: 13-14.
25. Brandon CL, Marinelli M, Baker LK, White FJ, (2001) Enhanced reactivity and vulnerability to cocaine following methylphenidate treatment in adolescent rats. Neuropsychopharmacology 25: 651-661.
26. Schenk S, Izenwasser S, (2002) Pretreatment with methylphenidate sensitizes rats to the reinforcing effects of cocaine. Pharmacol Biochem Behav 72: 651-657.
27. Volkow ND, Wang GJ, Fowler JS, Gatley SJ, Logan J, et al. (1998) Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Am J Psychiatry 155: 1325-1331.
28. Krause J, la Fougere C, Krause KH, Ackenheil M, Dresel SH, (2005) Influence of striatal dopamine transporter availability on the response to methylphenidate in adult patients with ADHD. European archives of psychiatry and clinical neuroscience 255: 428-431.
29. Volkow ND, Wang GJ, Newcorn J, Telang F, Solanto MV, et al. (2007) Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder. Archives of general psychiatry 64: 932-940.